Hypertension Trial, Recruiting NCT07565727 Sponsor: University of Tennessee Graduate School of Medicine Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07565727
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 45 years old
  • Pregnant people at any pre-pregnancy body weight or size
  • People who have at least one high-risk factor, or at least one moderate-risk factor, for a pregnancy complication called pre-eclampsia, based on recognised medical guidelines (confirm with trial site)
  • People who are willing to take aspirin as part of the study
  • People who are willing to take part in a 2-hour blood sugar test, surveys, breathing measurements, body composition measurements, and newborn measurements
  • People who are less than 18 weeks pregnant at the time of joining
  • People who can speak, read, and communicate in English

Who may not be able to join:

  • People who have Type 1 or Type 2 diabetes
  • People who currently have gestational diabetes (diabetes that developed during pregnancy)
  • People who have a current or active condition that affects their platelets or blood clotting ability (such as low platelet counts, ITP, TTP, or von Willebrand disease)
  • People who have a condition that increases the risk of blood clots (known as thrombophilia)
  • People who are currently taking anti-inflammatory pain medications such as ibuprofen or indomethacin for another condition
  • People who are currently taking certain medicines that affect the immune system, such as hydroxychloroquine or azathioprine
  • People who are currently using, or have recently used, steroid medications
  • People who are currently taking blood-thinning medications
  • People for whom aspirin is medically unsuitable
  • People with a molar pregnancy (a rare pregnancy complication where a fertilised egg develops abnormally)
  • People with kidney disease
  • People who are unable or unwilling to give formal consent to participate
  • People whose current mental health or personal circumstances may make it difficult to follow the study requirements, as assessed by the trial investigators

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 865-305-9367

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Tennessee Graduate School of Medicine
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Early Pregnancy Fasting Insulin (mIU/mL); Early Pregnancy Homeostatic Model Assessment for Insulin Resistance; Early Pregnancy Fasting Lipid Oxidation Rate (g/min); Late Pregnancy Fasting Insulin (mIU/mL); Late Pregnancy Homeostatic Model Assessment for Insulin Resistance; Late Pregnancy Fasting Lipid Oxidation Rate (g/min)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov